Promising fragile x drug moves to Long-Term safety check
NCT ID NCT05367960
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 21 times
Summary
This study looks at the long-term safety of a drug called BPN14770 in people with Fragile X syndrome. It includes about 314 adults and teens who already completed earlier studies of the drug. Everyone in this study will receive the drug for up to 4 years, and researchers will monitor side effects and cognitive function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAGILE X SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amnova Clinical Research
Irvine, California, 92604, United States
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Clinic for Special Children
Strasburg, Pennsylvania, 17579, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30322, United States
-
Greenwood Genetic Center
Greenville, South Carolina, 29605, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Kennedy Krieger Institute
Baltimore, Maryland, 21205, United States
-
MIND Institute UC Davis Medical Center
Sacramento, California, 95817, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Suburban Research Associates
Media, Pennsylvania, 19063, United States
-
Thompson Autism & Neurodevelopment Center - CHOC
Orange, California, 92828, United States
-
U Mass
Worcester, Massachusetts, 01655, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Utah and Primary Children's Hospital
Salt Lake City, Utah, 84113, United States
Conditions
Explore the condition pages connected to this study.